February 21, 2024

Playing with Light and AI: iLoF's Answer to Personalized Medicine

Michel Gagnon
Michel Gagnon
CEO of Stun&Awe

I had the incredible opportunity to sit down with Luis Valente, the CEO and co-founder of iLoF, for an enlightening conversation about his journey in the deep tech world and the pioneering work iLoF is doing in personalized medicine. Luis, who has been honored in the Forbes 30 under 30 list, shared the story behind iLoF, a company at the forefront of using AI to transform our approach to treating complex diseases.

During our chat, Luis opened up about the passion driving him and his team to tackle some of the healthcare sector's most pressing challenges. He detailed how iLoF is making it easier and faster for pharmaceutical companies and researchers to develop personalized medicines, ultimately aiming to deliver more effective treatments to patients. Luis didn't shy away from discussing the hurdles they've faced, including validating his idea, sourcing the right talent, navigating unforeseen challenges, and the ongoing quest for funding.

What stood out to me was Luis's vision for the future of iLoF. He's not just focused on overcoming current obstacles but is actively planning to expand the team, enhance their algorithms with more data, and scale up their business development efforts into 2024.

We also delved into some of the technical and strategic aspects of iLoF's work, from their approach to personalized medicine and data handling to their innovative strategies for patient selection in clinical trials. Luis even shared insights into the startup's business model and their 'foot in the door' strategy, which has been pivotal in navigating the complex regulatory landscape of the healthcare industry.

Hearing Luis talk about what keeps him up at night, the critical importance of patient selection in clinical trials, and iLoF's successes and future aspirations was truly inspiring. It was a conversation filled with valuable lessons for anyone interested in the intersection of technology, entrepreneurship, and healthcare.

Tune into this episode of Growth Leap to hear our deep dive into the story of iLoF and Luis Valente's entrepreneurial journey, and learn about the exciting potential of AI in revolutionizing personalized medicine.

Here's a sneak peek at what we dive into:

01:34 Understanding iLoF and Personalized Medicine

02:24 Data and iLoF's Approach to Personalized Medicine

05:21 400 Failed Clinical Trials and the Importance of Patient Selection

07:41 Apply the Netflix' Personalization Model to Clinical Trial

11:03 The Only Reason You Should Start a Deep Tech Company According to Luis

16:18 How Luis Started a Deep Tech Startup

19:41 How Luis Did 10 Interviews a Week for 10 Weeks to Validate a Problem at the Harvard/MIT Accelerator

21:43 How to Position Your Startup in a Highly Regulated Industry

25:21 iLof's Business Model and 'Foot on the Door' Strategy

27:18 The Harduous path for Alzheimer's Patient Selection in Trials

30:36 How Successful is iLof's Technology

31:43 What Keeps Luis Awake at Night

36:33 Fundraising and Investor Relations

40:32 Future Plans and Goals for the Next 12 Months

Podcast Transcript

Full Transcript →

Where to find Simon:

Where to find Michel: